Open AccessSevere pembrolizumab-induced gastritis in a patient with lung adenocarcinoma
Author(s) -
Cristina Pérez Santamaría,
Guillermo Castillo-López,
Isabel Curto-García,
Patricia Gómez Iglesias,
Mercedes Lumbreras Cabrera,
Lourdes Carreira Guillán
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.8319/2021
Subject(s) - medicine , pembrolizumab , adenocarcinoma , gastritis , lung , gastroenterology , general surgery , cancer , helicobacter pylori , immunotherapy
Cancer immunotherapy is an increasingly common treatment option based on anti-tumor immune response. However, a challenge is arising regarding its potential, which is the poorly understood recognized immune-mediated adverse effects.